Kary, S <br/><br/>
New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists.  [electronic resource] 

 -  Annals of the rheumatic diseases  Mar 2006 
 - 405-7 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0003-4967 
<br/><br/><label>Standard No.: </label>10.1136/ard.2005.037424  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Antirheumatic Agents--adverse effects<br/>Arthritis, Rheumatoid--drug therapy<br/>Etanercept<br/>Female<br/>Humans<br/>Immunoglobulin G--adverse effects<br/>Infliximab<br/>Male<br/>Middle Aged<br/>Psoriasis--chemically induced<br/>Receptors, Tumor Necrosis Factor<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors